Phenobarbital 30mg/1ml solution for injection ampoules Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

phenobarbital 30mg/1ml solution for injection ampoules

alliance healthcare (distribution) ltd - phenobarbital sodium - solution for injection - 30mg/1ml

PHENOBARBITAL SODIUM INJECTION, USP SOLUTION Canada - engleză - Health Canada

phenobarbital sodium injection, usp solution

sandoz canada incorporated - phenobarbital sodium - solution - 30mg - phenobarbital sodium 30mg - barbiturates

Phenobarbital Tablets, USP  
 CIV
Rx only Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

phenobarbital tablets, usp civ rx only

mckesson corporation dba sky packaging - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg - - sedative - anticonvulsant – for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. controlled substance – phenobarbital is a schedule iv drug. dependence – barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intox

PHENOBARBITAL liquid Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

phenobarbital liquid

atlantic biologicals corp - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - a. sedative b. anticonvulsant- for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. phenobarbital is a schedule iv drug. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administrations in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree to physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fa

Phenobarbital 30mg Tablets Malta - engleză - Medicines Authority

phenobarbital 30mg tablets

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - phenobarbital - tablet - phenobarbital 30 mg - antiepileptics

ORION PHENOBARBITAL ELIXIR phenobarbital 15mg/5mL oral liquid bottle Australia - engleză - Department of Health (Therapeutic Goods Administration)

orion phenobarbital elixir phenobarbital 15mg/5ml oral liquid bottle

orion laboratories pty ltd t/a perrigo australia - phenobarbital, quantity: 3 mg/ml - oral liquid, solution - excipient ingredients: purified water; ethanol; glycerol; sorbitol; flavour - indications as at 16 january 2002: treatment of epilepsy.